Search hospitals > Texas > Houston
Baylor College of Medicine
Claim this profileHouston, Texas 77030
Global Leader in Thyroid Fibrosis
Global Leader in Postprandial Fullness Syndrome
Conducts research for Breast Cancer
Conducts research for Pandemic Flu
Conducts research for Diabetes
1378 reported clinical trials
106 medical researchers
Summary
Baylor College of Medicine is a medical facility located in Houston, Texas. This center is recognized for care of Thyroid Fibrosis, Postprandial Fullness Syndrome, Breast Cancer, Pandemic Flu, Diabetes and other specialties. Baylor College of Medicine is involved with conducting 1,378 clinical trials across 1,426 conditions. There are 106 research doctors associated with this hospital, such as Jennifer Foster, MD, Patricia Baxter, MD, Mohamed O. Othman, MD, and Carlos Ramos, MD.Area of expertise
1Thyroid Fibrosis
Global LeaderCFTR positive
621+1G->T
CFTR
2Postprandial Fullness Syndrome
Global LeaderMECP2 positive
anti-Ro/SSA positive
MELAS
Top PIs
Jennifer Foster, MDBaylor College of Medicine/Dan L Duncan Comprehensive Cancer Center2 years of reported clinical research
Expert in Neuroblastoma
Expert in Cancer
34 reported clinical trials
53 drugs studied
Patricia Baxter, MDTexas Children's Hospital3 years of reported clinical research
Expert in Brain Tumor
Expert in Cerebral Gliomas
32 reported clinical trials
40 drugs studied
Mohamed O. Othman, MDBaylor College of Medicine4 years of reported clinical research
Studies Digestive Cancer
Studies Gastrointestinal Cancer
17 reported clinical trials
27 drugs studied
Carlos Ramos, MDHouston Methodist Hospital2 years of reported clinical research
Studies Lymphoma
Studies Non-Hodgkin's Lymphoma
12 reported clinical trials
16 drugs studied
Clinical Trials running at Baylor College of Medicine
Ovarian Cancer
Breast Cancer
Hepatocellular Carcinoma
Colorectal Cancer
Epilepsy
Crohn's Disease
Liver Cancer
Atrial Fibrillation
Lazy Eye
Chronic Obstructive Pulmonary Disease
Olvi-Vec + Chemotherapy
for Ovarian Cancer
The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objective response rate and progression-free survival observed in heavily pre-treated patients with platinum-resistant/refractory ovarian cancer. The phase II results also showed that the intra-peritoneal route of delivery was efficient in generating tumor cell killing and immune activation, and led to clinical reversal of platinum-resistance or refractoriness in this difficult-to-treat patient population.
Recruiting2 awards Phase 37 criteria
Heated Chemotherapy + Niraparib
for Ovarian Cancer
Patients will be registered prior to, during or at the completion of neoadjuvant chemotherapy (Paclitaxel 175 mg/m2 IV over 3 hours and Carboplatin AUC 6 IV on Day 1 every 21 days for 3-4 cycles). Registered patients who progress during neoadjuvant chemotherapy will not be eligible for iCRS and will be removed from the study. Following completion of neoadjuvant chemotherapy, interval cytoreductive surgery (iCRS) will be performed in the usual fashion in both arms. Patients will be randomized at the time of iCRS (iCRS must achieve no gross residual disease or no disease \>1.0 cm in largest diameter) to receive HIPEC or no HIPEC. Patients randomized to HIPEC (Arm A) will receive a single dose of cisplatin (100mg/m2 IP over 90 minutes at 42 C) as HIPEC. After postoperative recovery patients will receive standard post-operative platinum-based combination chemotherapy. Patients randomized to surgery only (Arm B) will receive postoperative standard chemotherapy after recovery from surgery. Both groups will receive an additional 2-3 cycles of platinum-based combination chemotherapy per institutional standard (Paclitaxel 175 mg/m2 IV over 3 hours and Carboplatin AUC 6 IV on Day 1 every 21 days for 2-3 cycles) for a maximum total of 6 cycles of chemotherapy (neoadjuvant plus post-operative cycles) followed by niraparib individualized dosing until progression or 36 months (if no evidence of disease).
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Baylor College of Medicine?
Baylor College of Medicine is a medical facility located in Houston, Texas. This center is recognized for care of Thyroid Fibrosis, Postprandial Fullness Syndrome, Breast Cancer, Pandemic Flu, Diabetes and other specialties. Baylor College of Medicine is involved with conducting 1,378 clinical trials across 1,426 conditions. There are 106 research doctors associated with this hospital, such as Jennifer Foster, MD, Patricia Baxter, MD, Mohamed O. Othman, MD, and Carlos Ramos, MD.
Where is Baylor College of Medicine located?
Baylor College of Medicine is located in the Texas Medical Center at 6651 Main St, Houston, TX, offering easy access via major freeways and thoroughfares.
Who should I call to ask about financial aid or insurance network?
For general inquiries at Baylor College of Medicine, please call (713) 798-4951. For financial assistance or billing concerns, contact the Baylor Scott & White Health Financial Assistance Program at 1-800-725-0024 (North Texas) or 1-800-994-0371 (Central Texas). The Baylor College of Medicine Billing Office is available at (713) 798-1900 for billing questions.
What insurance does Baylor College of Medicine accept?
The Baylor College of Medicine accepts a variety of insurance plans, including HMO, PPO, and POS managed care programs. Baylor Scott & White Health facilities accept Traditional Medicaid, Traditional Medicare, and any Medicare Supplement/Medigap plan, along with being contracted providers for insurance companies like Aetna, Blue Cross Blue Shield, Cigna, Humana, and more. Always verify coverage with the hospital or health plan before scheduling a visit or procedure.
What awards or recognition has Baylor College of Medicine received?
Baylor College of Medicine has been awarded a $14.85 million grant for neurological research and $24 million for cancer research and prevention. Additionally, they provide collaborative pilot grants in partnership with the University of Houston and have received awards funded by the DeBakey Medical Foundation.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.